Zia Fazili, Christine M Pfeiffer, Maya R Sternberg, Phuong Ngac, Ming Zhang, Krista S Crider, Jacqueline Leachman, Anne Williams, Jaime J Gahche, Neelima Paladugula, Kelly Hong, Christina Fischer
Folic acid supplement use was the strongest predictor of RBC folate biomarker concentrations and detection. Differences in the methyl-to-nonmethyl makeup of RBC TFOL by race/Hispanic origin suggest potential biological and/or genetic influences.
BACKGROUND: Red blood cell (RBC) total folate (TFOL) is an indicator of long-term folate status. Data on RBC folate forms are lacking. They may inform associations with health-related indicators.
OBJECTIVES: We aimed to describe associations between RBC folate forms and different factors in the United States population.
METHODS: We used data for 5 biologically active RBC folate forms [5-methyltetrahydrofolate (5-methylTHF), unmetabolized folic acid (UMFA), tetrahydrofolate (THF), 5-formyltetrahydrofolate (5-formylTHF), and 5,10-methenyltetrahydrofolate (5,10-methenylTHF); sum of which is TFOL] and 1 oxidation product of 5-methylTHF (MeFox) in persons aged ≥6 y participating in the National Health and Nutrition Examination Survey 2021-2023 cycle. We excluded pregnant or lactating females. We assessed bivariate associations between folate biomarkers [concentrations for TFOL, 5-methylTHF, THF, and MeFox; prevalences ≥limit of detection (LOD) for UMFA, 5-formylTHF, and 5,10-methenylTHF] and demographic, physiologic, and lifestyle variables in persons ≥20 y, accounting for the complex sample design. We estimated the impact of covariates on biomarker concentrations or odds ratios after covariate adjustment.
RESULTS: In persons ≥6 y (n=7126), geometric mean concentrations (nmol/L) were 913 (TFOL), 835 (5-methylTHF), 26.3 (THF), and 161 (MeFox); prevalences ≥LOD (%) were 43.6 (UMFA), 40.6 (5-formylTHF), and 73.0 (5,10-methenylTHF); and contributions to RBC TFOL were 92.7% (5-methylTHF), 5.02% (THF), and 1.61% (5,10-methenylTHF), varying by race/Hispanic origin. In persons ≥20 y, fasting status was not associated with biomarker concentrations or the prevalence ≥LOD. Biomarkers were significantly associated before and after covariate adjustment with age (TFOL; 5-methylTHF; THF; 5,10-methenylTHF), sex (MeFox), race/Hispanic origin (TFOL; 5-methylTHF; THF; MeFox), body mass index (TFOL; 5-methylTHF), tobacco use (TFOL; THF; MeFox), and folic acid supplement use (TFOL; 5-methylTHF; THF; MeFox; 5-formylTHF; 5,10-methenylTHF). Covariates explained ≤21% of the variation of 5-methylTHF, THF, or MeFox concentrations.
CONCLUSIONS: Folic acid supplement use was the strongest predictor of RBC folate biomarker concentrations and detection. Differences in the methyl-to-nonmethyl makeup of RBC TFOL by race/Hispanic origin suggest potential biological and/or genetic influences.